Intelligent Bio Solutions FY 2026: revenue $4.2M, up 38%; diluted EPS −$8.44

Key figures from this report

These are the numbers Intelligent Bio Solutions reported for the year ended Jun 30, 2026, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$4.2M+38% from $3.1M in FY 202510-K income statement, on EDGAR
2. Net income−$12.4MAgainst −$10.6M in FY 202510-K income statement, on EDGAR
3. Diluted EPS−$8.44Against −$2.00 in FY 202510-K income statement, on EDGAR
4. Cash and cash equivalents$4.0M+291% from $1.0M in FY 202510-K balance sheet, on EDGAR
5. Cash from operations−$11.9MAgainst −$9.7M in FY 202510-K cash flow statement, on EDGAR

Every year in the financial tables